Financhill
Back

BioNTech SE 10K Form

Sell
29

BNTX
BioNTech SE

Last Price:
$96.20
Seasonality Move:
1.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BNTX News And Ratings

See the #1 stock for the next 7 days that we like better than BNTX

BNTX Financial Statistics

Sales & Book Value

Annual Sales: $3B
Cash Flow: $-605.5M
Price / Cash Flow: 25.47
Annual Sales: $84.17
Price / Book: 1.18

Profitability

EPS (TTM): -2.99870
Net Income (TTM): $-717.6M
Gross Margin: $2.4B
Return on Equity: -3.39%
Return on Assets: -2.95%

BioNTech SE Earnings Forecast

Key BioNTech SE Financial Ratios

  • The Gross Profit Margin over the past 8 years for BNTX is 80.32%.
  • The Selling, General & Administrative Expenses for BNTX have been equal to 21.77% of Gross Profit Margin.
  • The Research & Development expenses have been 81.94% of Revenue.
  • The Net Earning history of BNTX is -24.18% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 3 years.

BioNTech SE Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BNTX
CUSIP: 09075V
Website: biontech.de

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 7.45
Quick Ratio: 7.26

Price-to-Earnings

Trailing P/E Ratio: 26.23
Forward P/E Ratio: 0

BNTX Technical Analysis vs Fundamental Analysis

Sell
29
BioNTech SE (BNTX) is a Sell

Is BioNTech SE a Buy or a Sell?

  • BioNTech SE stock is rated a Sell
    The current BioNTech SE [BNTX] share price is $99.27. The Score for BNTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.